ZORETIC RICHARD C 4

What Happened

• Richard C. Zoretic, a director of Molina Healthcare, was granted 405 shares of common stock under the issuer's 2025 Equity Incentive Plan on April 1, 2026. The grant was valued at about $55,007 based on the closing price of $135.82 per share. This was a compensatory equity award (transaction code A), not an open-market buy or sale.

Key Details

• Transaction date: April 1, 2026. Filing date: April 2, 2026.
• Grant: 405 shares @ $135.82 per share; total value ≈ $55,007.
• Plan and structure: Award granted under the 2025 Equity Incentive Plan. Annual director equity retainer is $220,000, with one quarter ($55,000) granted each quarter based on the closing price (footnotes F1–F3).
• Ownership after transaction: The filing does not list a post-transaction share count; filing notes all shares are held by the Richard Charles Zoretic Revocable Living Trust (F4).
• Transaction code: A (award/grant). No indication of late filing in this report.

Context

• This is a routine director compensation grant (quarterly portion of an annual equity retainer). Such awards reflect standard pay practices for board service and are not the same as a director purchasing shares on the open market or selling holdings.